![]() ![]() These returns cover a period from Januthrough January 2, 2023. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.28% per year. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. and Morningstar, Inc.Ĭopyright 2023 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606Īt the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Forbes Media, LLC Investor's Business Daily, Inc. Each of the company logos represented herein are trademarks of Microsoft Corporation Dow Jones & Company Nasdaq, Inc. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Aspira currently boasts a Zacks Rank of #2 (Buy), Compared to the company's year-ago EPS, this represents a change of +25%. AWH has returned 29.3% in the past month.Īspira's consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.06. Aspira ( AWH Quick Quote AWH - Free Report), another stock in the same industry, closed the last trading session 2.1% lower at $0.57. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >Īlphatec is part of the Zacks Medical - Instruments industry. The stock currently carries a Zacks Rank #3 (Hold). So, make sure to keep an eye on ATEC going forward to see if this recent jump can turn into more strength down the road. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.įor Alphatec, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Revenues are expected to be $105.7 million, up 42.9% from the year-ago quarter. This medical equipment and supplies holding company is expected to post quarterly loss of $0.30 per share in its upcoming report, which represents a year-over-year change of +25%. ![]() Per management, the transaction is likely to strengthen Alphatec’s balance sheet with additional capital that will allow company to continue to advance patient care and, as a result, create shareholder value, thereby boosting investors’ confidence. In January, Alphatec entered into a five-year agreement with Braidwell LP - an investment manager that has agreed to make a term loan of up to $150 million. full-year 2022 total revenue grew approximately 44% to over $350 million. This compares to the stock's 7.2% gain over the past four weeks.Īlphatec recorded a strong price rise on investors’ optimism surrounding its upbeat preliminary financial results for the fourth quarter and full year. ![]() The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. Alphatec ( ATEC Quick Quote ATEC - Free Report) shares ended the last trading session 8.4% higher at $14. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |